Clinical Trials in Houston

Showing 5061-5080 of 17,885 trials

Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction

NCT06059066

The purpose of this study is to evaluate and standardize the way providers perform OnabotulinumtoxinA (BTX-A) injections into the bladder for the diagnosis of neurogenic lower urinary tract dysfunction (NLUTD)/overactive bladder (OAB). NLUTD/OAB is a syndrome that affects many people, and includes urinary frequency, urinary urgency, urgency incontinence, and nocturia. This syndrome can be challenging to treat and often requires procedural management - including BTX-A injections into the bladder.

Neurogenic BladderLower Urinary Tract SymptomsOveractive Bladder+2 more

The Methodist Hospital Research Institute78 participantsStarted Oct 2023

Houston, Texas, United States

RECRUITINGNA< 1 mile

The Goodnight Screen Media Study

NCT05820555

To test the timing of evening tablet use on children's circadian phase and sleep (i.e., sleep onset and sleep duration) compared to no screen media use. To explore the effect of evening tablet use on children's inhibitory control and executive function.

SleepSleep Hygiene

Baylor College of Medicine180 participantsStarted Apr 2023

Houston, Texas, United States

TERMINATEDPhase 2< 1 mile

PRV-3279-2a Trial in Systemic Lupus

NCT05087628

The PREVAIL-2 study is designed to assess the safety and potential efficacy of PRV-3279 in flare prevention in systemic lupus erythematosus (SLE) patients with active disease after amelioration induced by corticosteroid treatment.

Systemic Lupus Erythematosus

Provention Bio, a Sanofi Company28 participantsStarted Jan 2022

Apple Valley, California, United States • Covina, California, United States • La Jolla, California, United States +33 more locations

Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction

The Goodnight Screen Media Study

PRV-3279-2a Trial in Systemic Lupus

Find Trials by Condition in Houston

Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dz

Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM

Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD

The EMBER Trial for Weight Management Engagement

A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization

The OBSERVE Protocol

Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout

Implantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness

Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation Ablation

Efficacy in iNPH Shunting (PENS) Trial

Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC

SHARPEN - Parkinson's Disease Dementia

Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma